These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1775903)

  • 1. [Stress fractures during fluoride therapy. Physiopathological value of histomorphometry].
    Toussirot E; Schiano A; Lafforgue P; Acquaviva PC; Roux H
    Rev Rhum Mal Osteoartic; 1991 Oct; 58(9):571-5. PubMed ID: 1775903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iliac bone biopsies at the time of periarticular stress fractures during fluoride therapy: comparison with pretreatment biopsies.
    Schnitzler CM; Mesquita JM; Gear KA; Robson HJ; Moodley GP; Smyth AE
    J Bone Miner Res; 1990 Feb; 5(2):141-52. PubMed ID: 2316402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vertebral fractures are associated with increased cortical porosity in iliac crest bone biopsy of men with idiopathic osteoporosis.
    Ostertag A; Cohen-Solal M; Audran M; Legrand E; Marty C; Chappard D; de Vernejoul MC
    Bone; 2009 Mar; 44(3):413-7. PubMed ID: 19071239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of osteoporosis with sodium fluoride and calcium: effects on vertebral fracture incidence and bone histomorphometry.
    Lane JM; Healey JH; Schwartz E; Vigorita VJ; Schneider R; Einhorn TA; Suda M; Robbins WC
    Orthop Clin North Am; 1984 Oct; 15(4):729-45. PubMed ID: 6493736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of fluoride on bone histology in postmenopausal osteoporosis depends on adequate fluoride absorption and retention.
    Budden FH; Bayley TA; Harrison JE; Josse RG; Murray TM; Sturtridge WC; Kandel R; Vieth R; Strauss AL; Goodwin S
    J Bone Miner Res; 1988 Apr; 3(2):127-32. PubMed ID: 3213607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between fluoride effects on bone histology and on bone mass in patients with postmenopausal osteoporosis.
    Harrison JE; Bayley TA; Josse RG; Murray TM; Sturtridge W; Williams C; Goodwin S; Tam C; Fornasier V
    Bone Miner; 1986 Sep; 1(4):321-33. PubMed ID: 3504712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G; Ziegler R
    Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of vertebral osteoporosis. Use of sodium fluoride and sodium monofluorophosphate in combination with calcium].
    Meunier PJ
    Fortschr Med; 1990 Jan; 108(1):45-8. PubMed ID: 2179080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microscopic morphology of fluoride-induced bone.
    Vigorita VJ; Suda MK
    Clin Orthop Relat Res; 1983; (177):274-82. PubMed ID: 6407795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histomorphometry. Method for evaluating the bone mass].
    Meunier PJ; Chavassieux P
    Rev Rhum Mal Osteoartic; 1985 Dec; 52(12):669-73. PubMed ID: 4095470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histological effects of the treatment of osteoporosis with the combination of sodium fluoride, vitamin D and calcium].
    Briançon D; Charhon S; Edouard C; Meunier PJ
    Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):693-8. PubMed ID: 7006045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
    Steiniche T
    APMIS Suppl; 1995; 51():1-44. PubMed ID: 7669370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography.
    Borah B; Dufresne TE; Chmielewski PA; Johnson TD; Chines A; Manhart MD
    Bone; 2004 Apr; 34(4):736-46. PubMed ID: 15050906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Loss of trabecular bone strength and bone quality after 5 years of fluoride therapy for osteoporosis].
    Søgaard CH; Mosekilde L; Richards A; Mosekilde L
    Ugeskr Laeger; 1995 Apr; 157(14):2004-8. PubMed ID: 7740640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone histology in postmenopausal osteoporosis--variations in cellular activity].
    Lozo P; Krpan D; Krvavica A; Vukelić Baturić T; Fistonić I; Kusec V
    Acta Med Croatica; 2004; 58(1):5-11. PubMed ID: 15125387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for the development of stress fractures during fluoride therapy for osteoporosis.
    Schnitzler CM; Wing JR; Mesquita JM; Gear AK; Robson HJ; Smyth AE
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S195-200. PubMed ID: 2339629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antifracture efficacy of alendronate.
    Seeman E
    Int J Clin Pract Suppl; 1999 Apr; 101():40-5. PubMed ID: 12675021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoride and bone: a second look. No use in osteoporosis.
    Prescrire Int; 1998 Aug; 7(36):110-1. PubMed ID: 10342949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.